InsidersTradesSigma
인바이오: insider trades · South Korea · DART (FSS)
DART:company-7dea84KR·DART (FSS)Mcap 24.5Bn€Basic Materials
Discover the full management transaction log of 인바이오, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Basic Materials sector, 인바이오 has published 4 insider filings. Market capitalisation: €24.5bn. The latest transaction was reported on 10 March 2026 (Purchase). Among the most active insiders: 조인선. The full history is accessible without an account.
4
Insider Decl.
0
Thresholds
€14,430
4 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2250.00 €
Analyst consensus
Income statement
Revenue33.95 Bn€
Gross profit11.81 Bn€35% margin
Net income1.01 Bn€3.0% margin
Valuation
Beta0.68
Balance sheet & cash
Market cap24.45 Bn€
Total debt14.06 Bn€
Free Cash Flow2.01 Bn€
Debt / Equity33%
Profitability & ownership
ROE2.4%
ROA0.8%
% insiders43.7%
% institutions0.0%
Last declaration on 10 March 2026
Declarations4 total
4 of 4 declarations